Search for: "Lonza Inc."
Results 1 - 20
of 23
Sort by Relevance
|
Sort by Date
17 Jun 2020, 1:12 am
By Michael Douglas and Mhairi Stewart Andrew Bell is a leader of private international law in Australia. [read post]
21 Jul 2015, 7:06 am
Administrative law — Unemployment benefits — Substantial evidence Katarzyna Haynesworth, appellant, appeals the judgment of the Circuit Court for Baltimore City that upheld the administrative ruling of the Board of Appeals of the Maryland Department of Labor, Licensing and Regulation which denied Mrs. [read post]
5 May 2015, 10:25 am
Filed: April 30, 2015Opinion by: James K. [read post]
6 Aug 2012, 7:55 am
Novartis Vaccines & Diagnostics, Inc. v. [read post]
18 Jul 2011, 1:46 pm
The SEC obtained asset freezes and other emergency relief against three Swiss-based entities it has charged with insider trading ahead of a July 11 public announcement that Swiss-based Lonza Group Ltd would be acquiring Connecticut-based Arch Chemicals Inc. [read post]
24 Apr 2011, 8:43 pm
Glaxo Group Ltd. et al. 2:11-cv-03065; filed April 12, 2011 in the Central District of California • Plaintiffs: Genentech, Inc.; City of Hope • Defendants: Glaxo Group Ltd.; GlaxoSmithKline LLC; Human Genome Sciences, Inc.; Lonza Biologics PLC; Lonza Biologics Inc. [read post]
19 Nov 2010, 7:55 am
Patent No. 7,166,692 owned by Lonza Walkersville Inc. and entitled INTRACELLULAR DELIVERY OF SMALL MOLECULES, PROTEINS AND NUCLEIC ACIDS. [read post]
19 Nov 2010, 7:55 am
Patent No. 7,166,692 owned by Lonza Walkersville Inc. and entitled INTRACELLULAR DELIVERY OF SMALL MOLECULES, PROTEINS AND NUCLEIC ACIDS. [read post]
1 Oct 2010, 9:01 am
Patent No. 6,376,677 owned by Lonza AG and entitled PROCESS FOR THE PREPARATION OF NICOTINIC ACID. [read post]
2 Sep 2010, 8:35 am
Patent No. 7,166,692 owned by Lonza Walkersville Inc. and entitled Intracellular Delivery of Small Molecules, Proteins, and Nucleic Acids. [read post]
22 Dec 2009, 8:57 pm
Cir. 2009) ("Because Lonza sought to introduce the testimony of an alleged prior inventor under § 102(g) for the purpose of invalidating a patent, Lonza was required to produce evidence corroborating Dr. [read post]
9 Sep 2009, 1:16 pm
Innova/Pure Water, Inc. v. [read post]
4 Sep 2009, 12:11 am
Instruments, Inc. v. [read post]
3 Sep 2009, 8:25 pm
Wang Labs., Inc. v. [read post]
17 Aug 2009, 8:01 am
In January of 2009, Teva and Swiss based Lonza Group formed a joint venture to manufacture and market a portfolio of “biosimilars. [read post]
17 Aug 2009, 8:01 am
In January of 2009, Teva and Swiss based Lonza Group formed a joint venture to manufacture and market a portfolio of “biosimilars. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
2 Jan 2008, 9:05 pm
Lonza Group AG v. [read post]
2 Dec 2007, 9:00 pm
Pyramide USA, Inc. v. [read post]
4 Nov 2007, 9:12 pm
The Maryland IP Law Blog (another LexBlog creation) posted about a District of Delaware court that upheld a jury verdict of patent infringement and plans to enter a permanent injunction against Lonza, Ltd., Nutrinova Inc. and Nutrinova Nutrition Specialties & Food Ingredients GmbH prohibiting the U.S. sale and use of a fatty acid product currently marketed under the brand name Lonza DHA for use in functional foods and dietary supplements.Thanks for… [read post]
